Sonova Holding (OTCMKTS:SONVY) Short Interest Up 1,008.0% in March

Sonova Holding (OTCMKTS:SONVY) saw a large growth in short interest in the month of March. As of March 13th, there was short interest totaling 11,701 shares, a growth of 1,008.0% from the February 26th total of 1,056 shares. Based on an average daily trading volume, of 96,203 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the company’s shares are short sold. Currently, 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 96,203 shares, the short-interest ratio is presently 0.1 days.

Wall Street Analyst Weigh In

Several research firms have commented on SONVY. Zacks Research raised shares of Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, February 9th. BNP Paribas Exane raised shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a research note on Tuesday, March 10th. Finally, Jefferies Financial Group lowered shares of Sonova from a “hold” rating to a “moderate sell” rating in a report on Wednesday, March 18th. Two equities research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Sonova has a consensus rating of “Moderate Buy”.

Sonova Stock Up 0.9%

Sonova stock traded up $0.38 during trading hours on Tuesday, hitting $43.29. The company had a trading volume of 93,868 shares, compared to its average volume of 49,630. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91. The company has a 50-day moving average price of $51.58 and a two-hundred day moving average price of $52.98. Sonova has a 1 year low of $42.26 and a 1 year high of $68.76.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.